User menu

Renal cell apoptosis induced by nephrotoxic drugs: cellular and molecular mechanisms and potential approaches to modulation

Bibliographic reference Servais, Hélène ; Ortiz, Alberto ; Devuyst, Olivier ; Denamur, Sophie ; Tulkens, Paul M. ; et. al. Renal cell apoptosis induced by nephrotoxic drugs: cellular and molecular mechanisms and potential approaches to modulation. In: Apoptosis : an international journal on programmed cell death, Vol. 13, no. 1, p. 11-32 (2008)
Permanent URL
  1. Lemasters JJ (2005) Dying a thousand deaths: redundant pathways from different organelles to apoptosis and necrosis. Gastroenterology 129:351–360
  2. Servais H, Van Der Smissen P, Thirion G et al (2005) Gentamicin-induced apoptosis in LLC-PK1 cells: involvement of lysosomes and mitochondria. Toxicol Appl Pharmacol 206:321–333
  3. Lee RH, Song JM, Park MY, Kang SK, Kim YK, Jung JS (2001) Cisplatin-induced apoptosis by translocation of endogenous Bax in mouse collecting duct cells. Biochem Pharmacol 62:1013–1023
  4. Raffray M, Cohen GM (1997) Apoptosis and necrosis in toxicology: a continuum or distinct modes of cell death? Pharmacol Ther 75:153–177
  5. Hauser P, Oberbauer R (2002) Tubular apoptosis in the pathophysiology of renal disease. Wien Klin Wochenschr 114:671–677
  6. Cummings J, Ward TH, Ranson M, Dive C (2004) Apoptosis pathway-targeted drugs–from the bench to the clinic. Biochim Biophys Acta 1705:53–66
  7. Broker LE, Kruyt FA, Giaccone G (2005) Cell death independent of caspases: a review. Clin Cancer Res 11:3155–3162
  8. Lavrik IN, Golks A, Krammer PH (2005) Caspases: pharmacological manipulation of cell death. J Clin Invest 115:2665–2672
  9. Kim R, Emi M, Tanabe K (2005) Role of mitochondria as the gardens of cell death. Cancer Chemother Pharmacol 57:545–553
  10. Daugas E, Nochy D, Ravagnan L et al (2000) Apoptosis-inducing factor (AIF): a ubiquitous mitochondrial oxidoreductase involved in apoptosis. FEBS Lett 476:118–123
  11. Ekert PG, Vaux DL (2005) The mitochondrial death squad: hardened killers or innocent bystanders? Curr Opin Cell Biol 17:626–630
  12. Schafer ZT, Kornbluth S (2006) The apoptosome: physiological, developmental, and pathological modes of regulation. Dev Cell 10:549–561
  13. Lalier L, Cartron PF, Juin P et al (2007) Bax activation and mitochondrial insertion during apoptosis. Apoptosis 12:887–896
  14. Ott M, Zhivotovsky B, Orrenius S (2007) Role of cardiolipin in cytochrome c release from mitochondria. Cell Death Differ 14:1243–1247
  15. Iverson SL, Orrenius S (2004) The cardiolipin-cytochrome c interaction and the mitochondrial regulation of apoptosis. Arch Biochem Biophys 423:37–46
  16. Scorrano L, Korsmeyer SJ (2003) Mechanisms of cytochrome c release by proapoptotic BCL-2 family members. Biochem Biophys Res Commun 304:437–444
  17. Krajewski S, Krajewska M, Shabaik A, Miyashita T, Wang HG, Reed JC (1994) Immunohistochemical determination of in vivo distribution of Bax, a dominant inhibitor of Bcl-2. Am J Pathol 145:1323–1336
  18. Kuwana T, Newmeyer DD (2003) Bcl-2-family proteins and the role of mitochondria in apoptosis. Curr Opin Cell Biol 15:691–699
  19. Robertson JD, Enoksson M, Suomela M, Zhivotovsky B, Orrenius S (2002) Caspase-2 acts upstream of mitochondria to promote cytochrome c release during etoposide-induced apoptosis. J Biol Chem 277:29803–29809
  20. Liston P, Fong WG, Korneluk RG (2003) The inhibitors of apoptosis: there is more to life than Bcl2. Oncogene 22:8568–8580
  21. Ruchalski K, Mao H, Li Z et al (2006) Distinct hsp70 domains mediate apoptosis-inducing factor release and nuclear accumulation. J Biol Chem 281:7873–7880
  22. Garrido Carmen, Brunet Mathilde, Didelot Celine, Zermati Yael, Schmitt Elise, Kroemer Guido, Heat Shock Proteins 27 and 70: Anti-Apoptotic Proteins with Tumorigenic Properties, 10.4161/cc.5.22.3448
  23. Chandler D, el Naggar AK, Brisbay S, Redline RW, McDonnell TJ (1994) Apoptosis and expression of the bcl-2 proto-oncogene in the fetal and adult human kidney: evidence for the contribution of bcl-2 expression to renal carcinogenesis. Hum Pathol 25:789–796
  24. Oberbauer R, Rohrmoser M, Regele H, Muhlbacher F, Mayer G (1999) Apoptosis of tubular epithelial cells in donor kidney biopsies predicts early renal allograft function. J Am Soc Nephrol 10:2006–2013
  25. Kroning R, Katz D, Lichtenstein AK, Nagami GT (1999) Differential effects of cisplatin in proximal and distal renal tubule epithelial cell lines. Br J Cancer 79:293–299
  26. Tarze A, Deniaud A, Le Bras M et al (2007) GAPDH, a novel regulator of the pro-apoptotic mitochondrial membrane permeabilization. Oncogene 26:2606–2620
  27. Servais H, Jossin Y, Van Bambeke F, Tulkens PM, Mingeot-Leclercq MP (2006) Gentamicin causes apoptosis at low concentrations in renal LLC-PK1 cells subjected to electroporation. Antimicrob Agents Chemother 50:1213–1221
  28. Justo P, Lorz C, Sanz A, Egido J, Ortiz A (2003) Intracellular mechanisms of cyclosporin A-induced tubular cell apoptosis. J Am Soc Nephrol 14:3072–3080
  29. Wei Q, Dong G, Franklin J, Dong Z (2007) The pathological role of Bax in cisplatin nephrotoxicity. Kidney Int 72:53–62
  30. Peherstorfer Elisabeth, Mayer Bernd, Boehm Stefan, Lukas Arno, Hauser Peter, Mayer Gert, Oberbauer Rainer, Effects of microinjection of synthetic Bcl-2 domain peptides on apoptosis of renal tubular epithelial cells, 10.1152/ajprenal.00317.2001
  31. Sawada M, Hayes P, Matsuyama S (2003) Cytoprotective membrane-permeable peptides designed from the Bax-binding domain of Ku70. Nat Cell Biol 5:352–357
  32. Retractions (2007). Nat Cell Biol 9:480
  33. Justo P, Sanz AB, Egido J, Ortiz A (2005) 3,4-Dideoxyglucosone-3-ene induces apoptosis in renal tubular epithelial cells. Diabetes 54:2424–2429
  34. Orlowski RZ (1999) The role of the ubiquitin-proteasome pathway in apoptosis. Cell Death Differ 6:303–313
  35. Zhu H, Zhang L, Dong F et al (2005) Bik/NBK accumulation correlates with apoptosis-induction by bortezomib (PS-341, Velcade) and other proteasome inhibitors. Oncogene 24:4993–4999
  36. Fribley Andrew, Wang Cun-Yu, Proteasome inhibitor induces apoptosis through induction of endoplasmic reticulum stress, 10.4161/cbt.5.7.2971
  37. Zavrski I, Kleeberg L, Kaiser M et al (2007) Proteasome as an emerging therapeutic target in cancer. Curr Pharm Des 13:471–485
  38. Chwieralski CE, Welte T, Buhling F (2006) Cathepsin-regulated apoptosis. Apoptosis 11:143–149
  39. Yuan XM, Li W, Dalen H et al (2002) Lysosomal destabilization in p53-induced apoptosis. Proc Natl Acad Sci USA 99:6286–6291
  40. Cao X, Deng X, May WS (2003) Cleavage of Bax to p18 Bax accelerates stress-induced apoptosis, and a cathepsin-like protease may rapidly degrade p18 Bax. Blood 102:2605–2614
  41. Szegezdi E, Logue SE, Gorman AM, Samali A (2006) Mediators of endoplasmic reticulum stress-induced apoptosis. EMBO Rep 7:880–885
  42. Goetz JG, Nabi IR (2006) Interaction of the smooth endoplasmic reticulum and mitochondria. Biochem Soc Trans 34:370–373
  43. Hetz C, Bernasconi P, Fisher J et al (2006) Proapoptotic BAX and BAK modulate the unfolded protein response by a direct interaction with IRE1alpha. Science 312:572–576
  44. Mathai JP, Germain M, Shore GC (2005) BH3-only BIK regulates BAX,BAK-dependent release of Ca2+ from endoplasmic reticulum stores and mitochondrial apoptosis during stress-induced cell death. J Biol Chem 280:23829–23836
  45. Zinszner H, Kuroda M, Wang X et al (1998) CHOP is implicated in programmed cell death in response to impaired function of the endoplasmic reticulum. Genes Dev 12:982–995
  46. Erdal H, Berndtsson M, Castro J, Brunk U, Shoshan MC, Linder S (2005) Induction of lysosomal membrane permeabilization by compounds that activate p53-independent apoptosis. Proc Natl Acad Sci USA 102:192–197
  47. Machamer CE (2003) Golgi disassembly in apoptosis: cause or effect? Trends Cell Biol 13:279–281
  48. Hicks SW, Machamer CE (2005) Golgi structure in stress sensing and apoptosis. Biochim Biophys Acta 1744:406–414
  49. Ortiz A, Lorz C, Catalan MP et al (2000) Expression of apoptosis regulatory proteins in tubular epithelium stressed in culture or following acute renal failure. Kidney Int 57:969–981
  50. Kataoka T (2005) The caspase-8 modulator c-FLIP. Crit Rev Immunol 25:31–58
  51. Lorz C, Justo P, Sanz AB, Egido J, Ortiz A (2005) Role of Bcl-xL in paracetamol-induced tubular epithelial cell death. Kidney Int 67:592–601
  52. Modjtahedi N, Giordanetto F, Madeo F, Kroemer G (2006) Apoptosis-inducing factor: vital and lethal. Trends Cell Biol 16:264–272
  53. Mao WP, Ye JL, Guan ZB et al (2007) Cadmium induces apoptosis in human embryonic kidney (HEK) 293 cells by caspase-dependent and -independent pathways acting on mitochondria. Toxicol In Vitro 21:343–354
  54. Kagami S, Kondo S (2004) Beta1-integrins and glomerular injury. J Med Invest 51:1–13
  55. Bijian K, Takano T, Papillon J, Khadir A, Cybulsky AV (2004) Extracellular matrix regulates glomerular epithelial cell survival and proliferation. Am J Physiol Renal Physiol 286:F255–F266
  56. Dutta J, Fan Y, Gupta N, Fan G, Gelinas C (2006) Current insights into the regulation of programmed cell death by NF-kappaB. Oncogene 25:6800–6816
  57. Park SJ, Jeong KS (2004) Cell-type-specific activation of mitogen-activated protein kinases in PAN-induced progressive renal disease in rats. Biochem Biophys Res Commun 323:1–8
  58. Awazu M, Omori S, Hida M (2002) MAP kinase in renal development. Nephrol Dial Transplant 17(Suppl 9):5–7
  59. Sen P, Mukherjee S, Ray D, Raha S (2003) Involvement of the Akt/PKB signaling pathway with disease processes. Mol Cell Biochem 253:241–246
  60. O’Dea EL, Barken D, Peralta RQ et al (2007) A homeostatic model of IkappaB metabolism to control constitutive NF-kappaB activity. Mol Syst Biol 3:111
  61. Heikaus S, Casliskan E, Mahotka C, Gabbert HE, Ramp U (2007) Differential gene expression in anticancer drug- and TRAIL-mediated apoptosis in renal cell carcinomas. Apoptosis 12:1645–1657
  62. Shetty S, Gladden JB, Henson ES et al (2002) Tumor necrosis factor-related apoptosis inducing ligand (TRAIL) up-regulates death receptor 5 (DR5) mediated by NFkappaB activation in epithelial derived cell lines. Apoptosis 7:413–420
  63. Efeyan Alejo, Serrano Manuel, p53: Guardian of the Genome and Policeman of the Oncogenes, 10.4161/cc.6.9.4211
  64. Vousden KH, Lane DP (2007) p53 in health and disease. Nat Rev Mol Cell Biol 8:275–283
  65. Ries F., Klastersky J., Nephrotoxicity Induced by Cancer Chemotherapy With Special Emphasis on Cisplatin Toxicity, 10.1016/s0272-6386(86)80112-3
  66. Kuhlmann MK, Burkhardt G, Kohler H (1997) Insights into potential cellular mechanisms of cisplatin nephrotoxicity and their clinical application. Nephrol Dial Transplant 12:2478–2480
  67. Endo T, Kimura O, Sakata M (2000) Carrier-mediated uptake of cisplatin by the OK renal epithelial cell line. Toxicology 146:187–195
  68. Ban M, Hettich D, Huguet N (1994) Nephrotoxicity mechanism of cis-platinum(II) diamine dichloride in mice. Toxicol Lett 71:161–168
  69. Huang Q, Dunn RT, Jayadev S et al (2001) Assessment of cisplatin-induced nephrotoxicity by microarray technology. Toxicol Sci 63:196–207
  70. Arany I, Safirstein RL (2003) Cisplatin nephrotoxicity. Semin Nephrol 23:460–464
  71. Arany I, Megyesi JK, Kaneto H, Price PM, Safirstein RL (2004) Cisplatin-induced cell death is EGFR/src/ERK signaling dependent in mouse proximal tubule cells. Am J Physiol Renal Physiol 287:F543–F549
  72. Dobyan DC, Levi J, Jacobs C, Kosek J, Weiner MW (1980) Mechanism of cis-platinum nephrotoxicity. II. Morphologic observations. J Pharmacol Exp Ther 213:551–556
  73. Kaushal GP, Kaushal V, Hong X, Shah SV (2001) Role and regulation of activation of caspases in cisplatin-induced injury to renal tubular epithelial cells. Kidney Int 60:1726–1736
  74. Wei Q, Dong G, Yang T, Megyesi J, Price PM, Dong Z (2007) Activation and Involvement of p53 in Cisplatin-induced Nephrotoxicity. Am J Physiol Renal Physiol 293:F1282–F1291
  75. Jiang M, Pabla N, Murphy RF et al (2007) Nutlin-3 protects kidney cells during cisplatin therapy by suppressing Bax/Bak activation. J Biol Chem 282:2636–2645
  76. Wang J, Pabla N, Wang CY, Wang W, Schoenlein PV, Dong Z (2006) Caspase-mediated cleavage of ATM during cisplatin-induced tubular cell apoptosis: inactivation of its kinase activity toward p53. Am J Physiol Renal Physiol 291:F1300–F1307
  77. Dippold WG, Jay G, DeLeo AB, Khoury G, Old LJ (1981) p53 transformation-related protein: detection by monoclonal antibody in mouse and human cells. Proc Natl Acad Sci USA 78:1695–1699
  78. Jiang M, Wei Q, Wang J et al (2006) Regulation of PUMA-alpha by p53 in cisplatin-induced renal cell apoptosis. Oncogene 25:4056–4066
  79. Seth R, Yang C, Kaushal V, Shah SV, Kaushal GP (2005) p53-dependent caspase-2 activation in mitochondrial release of apoptosis-inducing factor and its role in renal tubular epithelial cell injury. J Biol Chem 280:31230–31239
  80. Moll UM, Wolff S, Speidel D, Deppert W (2005) Transcription-independent pro-apoptotic functions of p53. Curr Opin Cell Biol 17:631–636
  81. Ramesh G, Reeves WB (2005) p38 MAP kinase inhibition ameliorates cisplatin nephrotoxicity in mice. Am J Physiol Renal Physiol 289:F166–F174
  82. Kim YK, Jung JS, Lee SH, Kim YW (1997) Effects of antioxidants and Ca2+ in cisplatin-induced cell injury in rabbit renal cortical slices. Toxicol Appl Pharmacol 146:261–269
  83. Zhou H, Kato A, Yasuda H et al (2004) The induction of cell cycle regulatory and DNA repair proteins in cisplatin-induced acute renal failure. Toxicol Appl Pharmacol 200:111–120
  84. Price PM, Yu F, Kaldis P et al (2006) Dependence of cisplatin-induced cell death in vitro and in vivo on cyclin-dependent kinase 2. J Am Soc Nephrol 17:2434–2442
  85. Yu F, Megyesi J, Safirstein RL, Price PM (2007) Involvement of the CDK2-E2F1 pathway in cisplatin cytotoxicity in vitro and in vivo. Am J Physiol Renal Physiol 293:F52–F59
  86. Momekov G, Konstantinov S, Topashka-Ancheva M, Bakalova A, Arpadjan S, Karaivanova M (2007) Cellular pharmacology, antineoplastic activity and low in vivo toxicity of a carboxylato-bridged platinum(II) complex bis(acetato)diammine-bis-micro-acetato diplatinum(II) dihydrate. Med Chem 3:157–165
  87. Mingeot-Leclercq MP, Tulkens PM (1999) Aminoglycosides: nephrotoxicity. Antimicrob Agents Chemother 43:1003–1012
  88. Fabre J, Rudhardt M, Blanchard P, Regamey C (1976) Persistence of sisomicin and gentamicin in renal cortex and medulla compared with other organs and serum of rats. Kidney Int 10:444–449
  89. Vandewalle A, Farman N, Morin JP, Fillastre JP, Hatt PY, Bonvalet JP (1981) Gentamicin incorporation along the nephron: autoradiographic study on isolated tubules. Kidney Int 19:529–539
  90. Sastrasinh M, Knauss TC, Weinberg JM, Humes HD (1982) Identification of the aminoglycoside binding site in rat renal brush border membranes. J Pharmacol Exp Ther 222:350–358
  91. Moestrup SK, Cui S, Vorum H et al (1995) Evidence that epithelial glycoprotein 330/megalin mediates uptake of polybasic drugs. J Clin Invest 96:1404–1413
  92. Silverblatt FJ, Kuehn C (1979) Autoradiography of gentamicin uptake by the rat proximal tubule cell. Kidney Int 15:335–345
  93. Giurgea-Marion L, Toubeau G, Laurent G, Heuson-Stiennon JA, Tulkens PM (1986) Impairment of lysosome-pinocytic vesicle fusion in rat kidney proximal tubules after treatment with gentamicin at low doses. Toxicol Appl Pharmacol 86:271–285
  94. El Mouedden M, Laurent G, Mingeot-Leclercq MP, Taper HS, Cumps J, Tulkens PM (2000) Apoptosis in renal proximal tubules of rats treated with low doses of aminoglycosides. Antimicrob Agents Chemother 44:665–675
  95. El Mouedden M, Laurent G, Mingeot-Leclercq MP, Tulkens PM (2000) Gentamicin-induced apoptosis in renal cell lines and embryonic rat fibroblasts. Toxicol Sci 56:229–239
  96. Sandoval RM, Molitoris BA (2004) Gentamicin traffics retrograde through the secretory pathway and is released in the cytosol via the endoplasmic reticulum. Am J Physiol Renal Physiol 286:F617–F624
  97. Mather M, Rottenberg H (2001) Polycations induce the release of soluble intermembrane mitochondrial proteins. Biochim Biophys Acta 1503:357–368
  98. Horibe T, Matsui H, Tanaka M et al (2004) Gentamicin binds to the lectin site of calreticulin and inhibits its chaperone activity. Biochem Biophys Res Commun 323:281–287
  99. Lesniak W, Pecoraro VL, Schacht J (2005) Ternary complexes of gentamicin with iron and lipid catalyze formation of reactive oxygen species. Chem Res Toxicol 18:357–364
  100. Li Can, Lim Sun Woo, Sun Bo Kyung, Yang Chul Woo, Chronic Cyclosporine Nephrotoxicity: New Insights and Preventive Strategies, 10.3349/ymj.2004.45.6.1004
  101. Fellstrom B (2004) Cyclosporine nephrotoxicity. Transplant Proc 36:220S–223S
  102. Stratta P, Canavese C, Quaglia M et al (2005) Posttransplantation chronic renal damage in nonrenal transplant recipients. Kidney Int 68:1453–1463
  103. Olyaei AJ, de Mattos AM, Bennett WM (2001) Nephrotoxicity of immunosuppressive drugs: new insight and preventive strategies. Curr Opin Crit Care 7:384–389
  104. Dieperink H, Kemp E, Leyssac PP et al (1986) Ketoconazole and cyclosporine A: combined effects on rat renal function and on serum and tissue cyclosporine A concentration. Clin Nephrol 25(Suppl 1):S137–S143
  105. del Moral RG, Olmo A, Aguilar M, O’Valle F (1998) P glycoprotein: a new mechanism to control drug-induced nephrotoxicity. Exp Nephrol 6:89–97
  106. Hauser IA, Schaeffeler E, Gauer S et al (2005) ABCB1 genotype of the donor but not of the recipient is a major risk factor for cyclosporine-related nephrotoxicity after renal transplantation. J Am Soc Nephrol 16:1501–1511
  107. Thomas SE, Andoh TF, Pichler RH et al (1998) Accelerated apoptosis characterizes cyclosporine-associated interstitial fibrosis. Kidney Int 53:897–908
  108. Shimizu H, Takahashi M, Takeda S et al (2004) Conversion from cyclosporine A to mycophenolate mofetil protects recipient kidney and prevents intimal hyperplasia in rat aortic allografts. Transpl Immunol 13:219–227
  109. Lee SY, Jo SK, Cho WY, Kim HK, Won NH (2004) The effect of alpha-melanocyte-stimulating hormone on renal tubular cell apoptosis and tubulointerstitial fibrosis in cyclosporine A nephrotoxicity. Transplantation 78:1756–1764
  110. Ortiz A, Lorz C, Catalan M, Ortiz A, Coca S, Egido J (1998) Cyclosporine A induces apoptosis in murine tubular epithelial cells: role of caspases. Kidney Int Suppl 68:S25–S29
  111. Amore A, Emancipator SN, Cirina P et al (2000) Nitric oxide mediates cyclosporine-induced apoptosis in cultured renal cells. Kidney Int 57:1549–1559
  112. Jeon SH, Piao YJ, Choi KJ et al (2005) Prednisolone suppresses cyclosporin A-induced apoptosis but not cell cycle arrest in MDCK cells. Arch Biochem Biophys 435:382–392
  113. Han SY, Chang EJ, Choi HJ et al (2006) Apoptosis by cyclosporine in mesangial cells. Transplant Proc 38:2244–2246
  114. Yang CW, Faulkner GR, Wahba IM et al (2002) Expression of apoptosis-related genes in chronic cyclosporine nephrotoxicity in mice. Am J Transplant 2:391–399
  115. Shihab FS, Bennett WM, Yi H, Andoh TF (2005) Effect of pirfenidone on apoptosis-regulatory genes in chronic cyclosporine nephrotoxicity. Transplantation 79:419–426
  116. Kim SI, Song HY, Hwang JH et al (2000) Cyclosporine nephrotoxicity: the mechanisms of cell injury by cyclosporine A in renal proximal tubular cells. Transplant Proc 32:1621–1622
  117. Fischer U, Schulze-Osthoff K (2005) New approaches and therapeutics targeting apoptosis in disease. Pharmacol Rev 57:187–215
  118. Lorz C, Benito-Martin A, Justo P et al (2006) Modulation of renal tubular cell survival: where is the evidence? Curr Med Chem 13:449–454
  119. Ciarimboli Giuliano, Ludwig Thomas, Lang Detlef, Pavenstädt Hermann, Koepsell Hermann, Piechota Hans-Jürgen, Haier Jörg, Jaehde Ulrich, Zisowsky Jochen, Schlatter Eberhard, Cisplatin Nephrotoxicity Is Critically Mediated via the Human Organic Cation Transporter 2, 10.1016/s0002-9440(10)61234-5
  120. Cihlar T, Ho ES, Lin DC, Mulato AS (2001) Human renal organic anion transporter 1 (hOAT1) and its role in the nephrotoxicity of antiviral nucleotide analogs. Nucleosides Nucleotides Nucleic Acids 20:641–648
  121. Nagai J, Takano M (2004) Molecular aspects of renal handling of aminoglycosides and strategies for preventing the nephrotoxicity. Drug Metab Pharmacokinet 19:159–170
  122. Takamoto Kozo, Kawada Manabu, Ikeda Daishiro, Yoshida Motonobu, Apolipoprotein E3 (apoE3) safeguards pig proximal tubular LLC-PK1 cells against reduction in SGLT1 activity induced by gentamicin C, 10.1016/j.bbagen.2004.12.006
  123. Perez M, Castilla M, Torres AM, Lazaro JA, Sarmiento E, Tejedor A (2004) Inhibition of brush border dipeptidase with cilastatin reduces toxic accumulation of cyclosporin A in kidney proximal tubule epithelial cells. Nephrol Dial Transplant 19:2445–2455
  124. Pingle SC, Mishra S, Marcuzzi A et al (2004) Osmotic diuretics induce adenosine A1 receptor expression and protect renal proximal tubular epithelial cells against cisplatin-mediated apoptosis. J Biol Chem 279:43157–43167
  125. Letai A (2005) Pharmacological manipulation of Bcl-2 family members to control cell death. J Clin Invest 115:2648–2655
  126. Gama V, Yoshida T, Gomez JA et al (2006) Involvement of the ubiquitin pathway in decreasing Ku70 levels in response to drug-induced apoptosis. Exp Cell Res 312:488–499
  127. Wang J, Wei Q, Wang CY, Hill WD, Hess DC, Dong Z (2004) Minocycline up-regulates Bcl-2 and protects against cell death in mitochondria. J Biol Chem 279:19948–19954
  128. Wada T, Pippin JW, Marshall CB, Griffin SV, Shankland SJ (2005) Dexamethasone prevents podocyte apoptosis induced by puromycin aminonucleoside: role of p53 and Bcl-2-related family proteins. J Am Soc Nephrol 16:2615–2625
  129. Wilson C, Foster GH, Bitzan M (2005) Silencing of Bak ameliorates apoptosis of human proximal tubular epithelial cells by Escherichia coli-derived Shiga toxin 2. Infection 33:362–367
  130. Zheng X, Zhang X, Sun H et al (2006) Protection of renal ischemia injury using combination gene silencing of complement 3 and caspase 3 genes. Transplantation 82:1781–1786
  131. Du C, Wang S, Diao H, Guan Q, Zhong R, Jevnikar AM (2006) Increasing resistance of tubular epithelial cells to apoptosis by shRNA therapy ameliorates renal ischemia-reperfusion injury. Am J Transplant 6:2256–2267
  132. Basnakian AG, Kaushal GP, Shah SV (2002) Apoptotic pathways of oxidative damage to renal tubular epithelial cells. Antioxid Redox Signal 4:915–924
  133. Shirwaikar A, Malini S, Kumari SC (2003) Protective effect of Pongamia pinnata flowers against cisplatin and gentamicin induced nephrotoxicity in rats. Indian J Exp Biol 41:58–62
  134. Juan SH, Chen CH, Hsu YH et al (2007) Tetramethylpyrazine protects rat renal tubular cell apoptosis induced by gentamicin. Nephrol Dial Transplant 22:732–739
  135. Ray SD, Patel D, Wong V, Bagchi D (2000) In vivo protection of dna damage associated apoptotic and necrotic cell deaths during acetaminophen-induced nephrotoxicity, amiodarone-induced lung toxicity and doxorubicin-induced cardiotoxicity by a novel IH636 grape seed proanthocyanidin extract. Res Commun Mol Pathol Pharmacol 107:137–166
  136. Al Ghamdi SS, Chatterjee PK, Raftery MJ, Thiemermann C, Yaqoob MM (2004) Role of cytochrome P4502E1 activation in proximal tubular cell injury induced by hydrogen peroxide. Ren Fail 26:103–110
  137. Liu H, Baliga R (2003) Cytochrome P450 2E1 null mice provide novel protection against cisplatin-induced nephrotoxicity and apoptosis. Kidney Int 63:1687–1696
  138. Messaris E, Antonakis PT, Memos N, Chatzigianni E, Leandros E, Konstadoulakis MM (2004) Deferoxamine administration in septic animals: improved survival and altered apoptotic gene expression. Int Immunopharmacol 4:455–459
  139. Ramesh Ganesan, Reeves W. Brian, TNFR2-mediated apoptosis and necrosis in cisplatin-induced acute renal failure, 10.1152/ajprenal.00101.2003
  140. Kim YK, Choi TR, Kwon CH, Kim JH, Woo JS, Jung JS (2003) Beneficial effect of pentoxifylline on cisplatin-induced acute renal failure in rabbits. Ren Fail 25:909–922
  141. Falk R, Hacham M, Nyska A, Foley JF, Domb AJ, Polacheck I (2005) Induction of interleukin-1beta, tumour necrosis factor-alpha and apoptosis in mouse organs by amphotericin B is neutralized by conjugation with arabinogalactan. J Antimicrob Chemother 55:713–720
  142. Shiozaki EN, Shi Y (2004) Caspases, IAPs and Smac/DIABLO: mechanisms from structural biology. Trends Biochem Sci 29:486–494
  143. Yang B, El Nahas AM, Fisher M et al (2004) Inhibitors directed towards caspase-1 and −3 are less effective than pan caspase inhibition in preventing renal proximal tubular cell apoptosis. Nephron Exp Nephrol 96:e39–e51
  144. Ortiz A, Justo P, Sanz A et al (2005) Tubular cell apoptosis and cidofovir-induced acute renal failure. Antivir Ther 10:185–190
  145. Yang W, Guastella J, Huang JC et al (2003) MX1013, a dipeptide caspase inhibitor with potent in vivo antiapoptotic activity. Br J Pharmacol 140:402–412
  146. Cai SX, Guan L, Jia S et al (2004) Dipeptidyl aspartyl fluoromethylketones as potent caspase inhibitors: SAR of the N-protecting group. Bioorg Med Chem Lett 14:5295–5300
  147. Tao Y, Kim J, Faubel S et al (2005) Caspase inhibition reduces tubular apoptosis and proliferation and slows disease progression in polycystic kidney disease. Proc Natl Acad Sci USA 102:6954–6959
  148. Fischer U, Janicke RU, Schulze-Osthoff K (2003) Many cuts to ruin: a comprehensive update of caspase substrates. Cell Death Differ 10:76–100
  149. Cilenti L, Kyriazis GA, Soundarapandian MM et al (2005) Omi/HtrA2 protease mediates cisplatin-induced cell death in renal cells. Am J Physiol Renal Physiol 288:F371–F379
  150. Jo SK, Cho WY, Sung SA, Kim HK, Won NH (2005) MEK inhibitor, U0126, attenuates cisplatin-induced renal injury by decreasing inflammation and apoptosis. Kidney Int 67:458–466
  151. Imai E, Isaka Y (2002) Targeting growth factors to the kidney: myth or reality? Curr Opin Nephrol Hypertens 11:49–57
  152. Ramesh G, Reeves WB (2004) Inflammatory cytokines in acute renal failure. Kidney Int Suppl (91):S56–S61
  153. Patrick DM, Leone AK, Shellenberger JJ, Dudowicz KA, King JM (2006) Proinflammatory cytokines tumor necrosis factor-alpha and interferon-gamma modulate epithelial barrier function in Madin-Darby canine kidney cells through mitogen activated protein kinase signaling. BMC Physiol 6:2
  154. Jung JY, Song JH, Li C et al (2005) Expression of epidermal growth factor in the developing rat kidney. Am J Physiol Renal Physiol 288:F227–F235
  155. Coimbra TM, Cieslinski DA, Humes HD (1990) Epidermal growth factor accelerates renal repair in mercuric chloride nephrotoxicity. Am J Physiol 259:F438–F443
  156. Daemen MA, van't Veer C, Denecker G et al (1999) Inhibition of apoptosis induced by ischemia-reperfusion prevents inflammation. J Clin Invest 104:541–549
  157. Varlam DE, Siddiq MM, Parton LA, Russmann H (2001) Apoptosis contributes to amphotericin B-induced nephrotoxicity. Antimicrob Agents Chemother 45:679–685
  158. Ernst F, Hetzel S, Stracke S et al (2001) Renal proximal tubular cell growth and differentiation are differentially modulated by renotropic growth factors and tyrosine kinase inhibitors. Eur J Clin Invest 31:1029–1039
  159. Mizui M, Isaka Y, Takabatake Y et al (2004) Electroporation-mediated HGF gene transfer ameliorated cyclosporine nephrotoxicity. Kidney Int 65:2041–2053
  160. Kiley SC, Thornhill BA, Tang SS, Ingelfinger JR, Chevalier RL (2003) Growth factor-mediated phosphorylation of proapoptotic BAD reduces tubule cell death in vitro and in vivo. Kidney Int 63:33–42
  161. Nishida M, Fujimoto S, Toiyama K, Sato H, Hamaoka K (2004) Effect of hematopoietic cytokines on renal function in cisplatin-induced ARF in mice. Biochem Biophys Res Commun 324:341–347
  162. Alvarez Arroyo MV, Suzuki Y, Yague S et al (2002) Role of endogenous vascular endothelial growth factor in tubular cell protection against acute cyclosporine toxicity. Transplantation 74:1618–1624
  163. Hiromura K, Pippin JW, Fero ML, Roberts JM, Shankland SJ (1999) Modulation of apoptosis by the cyclin-dependent kinase inhibitor p27(Kip1). J Clin Invest 103:597–604
  164. Bukanov NO, Smith LA, Klinger KW, Ledbetter SR, Ibraghimov-Beskrovnaya O (2006) Long-lasting arrest of murine polycystic kidney disease with CDK inhibitor roscovitine. Nature 444:949–952
  165. Price PM, Safirstein RL, Megyesi J (2004) Protection of renal cells from cisplatin toxicity by cell cycle inhibitors. Am J Physiol Renal Physiol 286:F378–F384
  166. Charlwood J, Skehel JM, King N et al (2002) Proteomic analysis of rat kidney cortex following treatment with gentamicin. J Proteome Res 1:73–82
  167. Amin RP, Vickers AE, Sistare F et al (2004) Identification of putative gene based markers of renal toxicity. Environ Health Perspect 112:465–479
  168. Kramer Jeffrey A., Pettit Syril D., Amin Rupesh P., Bertram Timothy A., Car Bruce, Cunningham Michael, Curtiss Sandra W., Davis John W., Kind Clive, Lawton Michael, Naciff Jorge M., Oreffo Victor, Roman Richard J., Sistare Frank D., Stevens James, Thompson Karol, Vickers Alison E., Wild Stacey, Afshari Cynthia A., Overview of the Application of Transcription Profiling Using Selected Nephrotoxicants for Toxicology Assessment, 10.1289/ehp.6673
  169. Aicher L, Wahl D, Arce A, Grenet O, Steiner S (1998) New insights into cyclosporine A nephrotoxicity by proteome analysis. Electrophoresis 19:1998–2003
  170. Bandara LR, Kelly MD, Lock EA, Kennedy S (2003) A correlation between a proteomic evaluation and conventional measurements in the assessment of renal proximal tubular toxicity. Toxicol Sci 73:195–206
  171. Vickers AE, Rose K, Fisher R, Saulnier M, Sahota P, Bentley P (2004) Kidney slices of human and rat to characterize cisplatin-induced injury on cellular pathways and morphology. Toxicol Pathol 32:577–590
  172. Thompson Karol L., Afshari Cynthia A., Amin Rupesh P., Bertram Timothy A., Car Bruce, Cunningham Michael, Kind Clive, Kramer Jeffrey A., Lawton Michael, Mirsky Michael, Naciff Jorge M., Oreffo Victor, Pine P. Scott, Sistare Frank D., Identification of Platform-Independent Gene Expression Markers of Cisplatin Nephrotoxicity, 10.1289/ehp.6676
  173. Bleasby K, Hall LA, Perry JL, Mohrenweiser HW, Pritchard JB (2005) Functional consequences of single nucleotide polymorphisms in the human organic anion transporter hOAT1 (SLC22A6). J Pharmacol Exp Ther 314:923–931
  174. Lorz C, Justo P, Sanz A, Subira D, Egido J, Ortiz A (2004) Paracetamol-induced renal tubular injury: a role for ER stress. J Am Soc Nephrol 15:380–389
  175. Zhang J, Clark JR Jr, Herman EH, Ferrans VJ (1996) Doxorubicin-induced apoptosis in spontaneously hypertensive rats: differential effects in heart, kidney and intestine, and inhibition by ICRF-187. J Mol Cell Cardiol 28:1931–1943
  176. Cheng CY, Sue YM, Chen CH et al (2006) Tetramethylpyrazine attenuates adriamycin-induced apoptotic injury in rat renal tubular cells NRK-52E. Planta Med 72:888–893
  177. Aravindan N, Cata JP, Hoffman L et al (2006) Effects of isoflurane, pentobarbital, and urethane on apoptosis and apoptotic signal transduction in rat kidney. Acta Anaesthesiol Scand 50:1229–1237
  178. Thevenod F (2003) Nephrotoxicity and the proximal tubule. Insights from cadmium. Nephron Physiol 93:87–93
  179. Mejia-Villet JM, Ramirez V, Cruz C, Uribe N, Gamba G, Bobadilla NA (2007) Renal ischemia/reperfusion injury is prevented by the mineralocorticoid receptor blocker spironolactone. Am J Physiol Renal Physiol 293:F78–F86
  180. Takeda M, Kobayashi M, Shirato I, Osaki T, Endou H (1997) Cisplatin-induced apoptosis of immortalized mouse proximal tubule cells is mediated by interleukin-1 beta converting enzyme (ICE) family of proteases but inhibited by overexpression of Bcl-2. Arch Toxicol 71:612–621
  181. Takeda M, Kobayashi M, Shirato I, Endou H (1998) Involvement of macromolecule synthesis, endonuclease activation and c-fos expression in cisplatin-induced apoptosis of mouse proximal tubule cells. Toxicol Lett 94:83–92
  182. Sheikh-Hamad D, Nadkarni V, Choi YJ et al (2001) Cyclosporine A inhibits the adaptive responses to hypertonicity: a potential mechanism of nephrotoxicity. J Am Soc Nephrol 12:2732–2741
  183. Lantum HB, Baggs RB, Krenitsky DM, Anders MW (2002) Nephrotoxicity of chlorofluoroacetic acid in rats. Toxicol Sci 70:261–268
  184. Hickey EJ, Raje RR, Reid VE, Gross SM, Ray SD (2001) Diclofenac induced in vivo nephrotoxicity may involve oxidative stress-mediated massive genomic DNA fragmentation and apoptotic cell death. Free Radic Biol Med 31:139–152
  185. Creydt VP, Silberstein C, Zotta E, Ibarra C (2006) Cytotoxic effect of Shiga toxin-2 holotoxin and its B subunit on human renal tubular epithelial cells. Microbes Infect 8:410–419
  186. Karpman D, Hakansson A, Perez MT et al (1998) Apoptosis of renal cortical cells in the hemolytic-uremic syndrome: in vivo and in vitro studies. Infect Immun 66:636–644
  187. Cunningham P. N., Dyanov H. M., Park P., Wang J., Newell K. A., Quigg R. J., Acute Renal Failure in Endotoxemia Is Caused by TNF Acting Directly on TNF Receptor-1 in Kidney, 10.4049/jimmunol.168.11.5817
  188. Cunningham P. N., Wang Y., Guo R., He G., Quigg R. J., Role of Toll-Like Receptor 4 in Endotoxin-Induced Acute Renal Failure, 10.4049/jimmunol.172.4.2629
  189. Dharnidharka VR, Nadeau K, Cannon CL, Harris HW, Rosen S (1998) Ciprofloxacin overdose: acute renal failure with prominent apoptotic changes. Am J Kidney Dis 31:710–712
  190. Duncan-Achanzar KB, Jones JT, Burke MF, Carter DE, Laird HE (1996) Inorganic mercury chloride-induced apoptosis in the cultured porcine renal cell line LLC-PK1. J Pharmacol Exp Ther 277:1726–1732
  191. Milutinovic A, Zivin M, Zorc-Pleskovic R, Sedmak B, Suput D (2003) Nephrotoxic effects of chronic administration of microcystins -LR and -YR. Toxicon 42:281–288
  192. Kamp HG, Eisenbrand G, Schlatter J, Wurth K, Janzowski C (2005) Ochratoxin A: induction of (oxidative) DNA damage, cytotoxicity and apoptosis in mammalian cell lines and primary cells. Toxicology 206:413–425
  193. Sauvant C, Holzinger H, Gekle M (2005) Proximal tubular toxicity of ochratoxin A is amplified by simultaneous inhibition of the extracellular signal-regulated kinases 1/2. J Pharmacol Exp Ther 313:234–241
  194. Cao LC, Honeyman TW, Cooney R, Kennington L, Scheid CR, Jonassen JA (2004) Mitochondrial dysfunction is a primary event in renal cell oxalate toxicity. Kidney Int 66:1890–1900
  195. Duan S, Zhou X, Liu F et al (2006) Comparative cytotoxicity of high-osmolar and low-osmolar contrast media on HKCs in vitro. J Nephrol 19:717–724
  196. Hizoh I, Strater J, Schick CS, Kubler W, Haller C (1998) Radiocontrast-induced DNA fragmentation of renal tubular cells in vitro: role of hypertonicity. Nephrol Dial Transplant 13:911–918
  197. Garofalo AS, Borges FT, Dalboni MA, Pavao dos Santos OF (2007) Reactive oxygen species independent cytotoxicity induced by radiocontrast agents in tubular cells (LLC-PK1 and MDCK). Ren Fail 29:121–131
  198. Itoh Y, Yano T, Sendo T et al (2006) Involvement of de novo ceramide synthesis in radiocontrast-induced renal tubular cell injury. Kidney Int 69:288–297
  199. Lieberthal W, Fuhro R, Andry CC et al (2001) Rapamycin impairs recovery from acute renal failure: role of cell-cycle arrest and apoptosis of tubular cells. Am J Physiol Renal Physiol 281:F693–F706
  200. Blanco-Colio LM, Justo P, Daehn I, Lorz C, Ortiz A, Egido J (2003) Bcl-xL overexpression protects from apoptosis induced by HMG-CoA reductase inhibitors in murine tubular cells. Kidney Int 64:181–191
  201. Loffing J, Loffing-Cueni D, Hegyi I et al (1996) Thiazide treatment of rats provokes apoptosis in distal tubule cells. Kidney Int 50:1180–1190
  202. Markowitz GS, Fine PL, Stack JI et al (2003) Toxic acute tubular necrosis following treatment with zoledronate (Zometa). Kidney Int 64:281–289
  203. Chen CH, Lin H, Hsu YH et al (2006) The protective effect of prostacyclin on adriamycin-induced apoptosis in rat renal tubular cells. Eur J Pharmacol 529:8–15
  204. Schwerdt G, Freudinger R, Schuster C, Weber F, Thews O, Gekle M (2005) Cisplatin-induced apoptosis is enhanced by hypoxia and by inhibition of mitochondria in renal collecting duct cells. Toxicol Sci 85:735–742
  205. Sheikh-Hamad D, Cacini W, Buckley AR et al (2004) Cellular and molecular studies on cisplatin-induced apoptotic cell death in rat kidney. Arch Toxicol 78:147–155
  206. Baek SM, Kwon CH, Kim JH, Woo JS, Jung JS, Kim YK (2003) Differential roles of hydrogen peroxide and hydroxyl radical in cisplatin-induced cell death in renal proximal tubular epithelial cells. J Lab Clin Med 142:178–186
  207. Satoh M, Kashihara N, Fujimoto S et al (2003) A novel free radical scavenger, edarabone, protects against cisplatin-induced acute renal damage in vitro and in vivo. J Pharmacol Exp Ther 305:1183–1190
  208. Park MS, De Leon M, Devarajan P (2002) Cisplatin induces apoptosis in LLC-PK1 cells via activation of mitochondrial pathways. J Am Soc Nephrol 13:858–865
  209. Davis CA, Nick HS, Agarwal A (2001) Manganese superoxide dismutase attenuates Cisplatin-induced renal injury: importance of superoxide. J Am Soc Nephrol 12:2683–2690
  210. Kruidering M, van de WB, de Heer E, Mulder GJ, Nagelkerke JF (1997) Cisplatin-induced nephrotoxicity in porcine proximal tubular cells: mitochondrial dysfunction by inhibition of complexes I to IV of the respiratory chain. J Pharmacol Exp Ther 280:638–649
  211. Zhang J, Duarte CG, Ellis S (1999) Contrast medium- and mannitol-induced apoptosis in heart and kidney of SHR rats. Toxicol Pathol 27:427–435
  212. Jin QH, Zhao B, Zhang XJ (2004) Cytochrome c release and endoplasmic reticulum stress are involved in caspase-dependent apoptosis induced by G418. Cell Mol Life Sci 61:1816–1825
  213. Cummings BS, McHowat J, Schnellmann RG (2004) Role of an endoplasmic reticulum Ca2+-independent phospholipase A2 in cisplatin-induced renal cell apoptosis. J Pharmacol Exp Ther 308:921–928
  214. Tervahartiala P, Kivisaari L, Kivisaari R, Vehmas T, Virtanen I (1997) Structural changes in the renal proximal tubular cells induced by iodinated contrast media. Nephron 76:96–102
  215. Humes HD, Sastrasinh M, Weinberg JM (1984) Calcium is a competitive inhibitor of gentamicin-renal membrane binding interactions and dietary calcium supplementation protects against gentamicin nephrotoxicity. J Clin Invest 73:134–147
  216. Giuliano RA, Verpooten GA, Verbist L, Wedeen RP, De Broe ME (1986) In vivo uptake kinetics of aminoglycosides in the kidney cortex of rats. J Pharmacol Exp Ther 236:470–475
  217. Oyama Y, Takeda T, Hama H et al (2005) Evidence for megalin-mediated proximal tubular uptake of L-FABP, a carrier of potentially nephrotoxic molecules. Lab Invest 85:522–531
  218. Chiu PJ, Miller GH, Long JF, Waitz JA (1979) Renal uptake and nephrotoxicity of gentamicin during urinary alkalinization in rats. Clin Exp Pharmacol Physiol 6:317–326
  219. Xiao T, Choudhary S, Zhang W, Ansari NH, Salahudeen A (2003) Possible involvement of oxidative stress in cisplatin-induced apoptosis in LLC-PK1 cells. J Toxicol Environ Health A 66:469–479
  220. Tayem Y, Johnson TR, Mann BE, Green CJ, Motterlini R (2006) Protection against cisplatin-induced nephrotoxicity by a carbon monoxide-releasing molecule. Am J Physiol Renal Physiol 290:F789–F794
  221. Nagothu KK, Bhatt R, Kaushal GP, Portilla D (2005) Fibrate prevents cisplatin-induced proximal tubule cell death. Kidney Int 68:2680–2693
  222. Lee S, Kim W, Moon SO et al (2006) Rosiglitazone ameliorates cisplatin-induced renal injury in mice. Nephrol Dial Transplant 21:2096–2105
  223. Francescato HD, Costa RS, Scavone C, Coimbra TM (2007) Parthenolide reduces cisplatin-induced renal damage. Toxicology 230:64–75
  224. Okuda M, Masaki K, Fukatsu S, Hashimoto Y, Inui K (2000) Role of apoptosis in cisplatin-induced toxicity in the renal epithelial cell line LLC-PK1. Implication of the functions of apical membranes. Biochem Pharmacol 59:195–201
  225. Iguchi T, Nishikawa M, Chang B et al (2004) Edaravone inhibits acute renal injury and cyst formation in cisplatin-treated rat kidney. Free Radic Res 38:333–341
  226. Sueishi K, Mishima K, Makino K et al (2002) Protection by a radical scavenger edaravone against cisplatin-induced nephrotoxicity in rats. Eur J Pharmacol 451:203–208
  227. Santos NA, Bezerra CS, Martins NM, Curti C, Bianchi ML, Santos AC (2007) Hydroxyl radical scavenger ameliorates cisplatin-induced nephrotoxicity by preventing oxidative stress, redox state unbalance, impairment of energetic metabolism and apoptosis in rat kidney mitochondria. Cancer Chemother Pharmacol 61:145–155
  228. Lee S, Moon SO, Kim W et al (2006) Protective role of L-2-oxothiazolidine-4-carboxylic acid in cisplatin-induced renal injury. Nephrol Dial Transplant 21:2085–2095
  229. Ikari A, Nagatani Y, Tsukimoto M, Harada H, Miwa M, Takagi K (2005) Sodium-dependent glucose transporter reduces peroxynitrite and cell injury caused by cisplatin in renal tubular epithelial cells. Biochim Biophys Acta 1717:109–117
  230. Martinez-Salgado C, Eleno N, Morales AI, Perez-Barriocanal F, Arevalo M, Lopez-Novoa JM (2004) Gentamicin treatment induces simultaneous mesangial proliferation and apoptosis in rats. Kidney Int 65:2161–2171
  231. Parlakpinar H, Tasdemir S, Polat A et al (2006) Protective effect of chelerythrine on gentamicin-induced nephrotoxicity. Cell Biochem Funct 24:41–48
  232. Bledsoe G, Crickman S, Mao J et al (2006) Kallikrein/kinin protects against gentamicin-induced nephrotoxicity by inhibition of inflammation and apoptosis. Nephrol Dial Transplant 21:624–633
  233. Spargias K, Alexopoulos E, Kyrzopoulos S et al (2004) Ascorbic acid prevents contrast-mediated nephropathy in patients with renal dysfunction undergoing coronary angiography or intervention. Circulation 110:2837–2842
  234. Itoh Y, Yano T, Sendo T, Oishi R (2005) Clinical and experimental evidence for prevention of acute renal failure induced by radiographic contrast media. J Pharmacol Sci 97:473–488
  235. Gibson EM, Henson ES, Haney N, Villanueva J, Gibson SB (2002) Epidermal growth factor protects epithelial-derived cells from tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by inhibiting cytochrome c release. Cancer Res 62:488–496
  236. Liu Y, Sun AM, Dworkin LD (1998) Hepatocyte growth factor protects renal epithelial cells from apoptotic cell death. Biochem Biophys Res Commun 246:821–826
  237. Ling H, Li X, Jha S et al (2003) Therapeutic role of TGF-beta-neutralizing antibody in mouse cyclosporin A nephropathy: morphologic improvement associated with functional preservation. J Am Soc Nephrol 14:377–388